Payment of 8770 shares by Ziegler Paul Jr of ViewRay subject to Rule 16b-3
VRAYDelisted Stock | USD 0.04 0 5.67% |
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
ViewRay |
Filed transaction by Viewray Inc officer. Payment of exercise price or tax liability by delivering or withholding securities
Read at macroaxis.com
ViewRay Fundamental Analysis
We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
ViewRay is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
ViewRay Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.
Peers
ViewRay Related Equities
BBLG | Bone Biologics | 5.56 | ||||
ESTA | Establishment Labs | 3.93 | ||||
HSCS | Heart Test | 1.06 | ||||
DCTH | Delcath Systems | 0.08 | ||||
INGN | Inogen | 0.23 | ||||
AXGN | Axogen | 0.42 | ||||
SGHT | Sight Sciences | 1.11 | ||||
AORT | Artivion | 1.16 | ||||
AVNS | Avanos Medical | 1.49 | ||||
ATEC | Alphatec Holdings | 1.50 | ||||
OFIX | Orthofix Medical | 1.68 | ||||
VVOS | Vivos Therapeutics | 2.31 | ||||
ANIK | Anika Therapeutics | 2.46 | ||||
CVRX | CVRx | 3.30 | ||||
NPCE | Neuropace | 5.99 | ||||
TIVC | Tivic Health | 14.29 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |